Home > Ireland > Cork start-up wins Ireland Funds Business Plan Competition

Cork start-up wins Ireland Funds Business Plan Competition

Written by Robert McHugh, on 23rd Jun 2016. Edited on 24th Jun 2016 Posted in Ireland

article headline

It was announced today that Cork start-up, Sothic Bioscience, has won €10,000 as part of the annual Ireland Funds Business Plan Competition for their biosynthetic replacement of an animal-derived product used widely in the pharmaceutical and medical sectors.

Limulus Amebocyte Lysate (LAL) is an extract found in the distinctive blue blood of the horseshoe crab. It is the gold standard in validating every medicine or medical equipment for human use as LAL identifies whether products are endotoxins and pyrogen-free. 

Finding an alternative to LAL was a challenge that Founder and CEO Stephen Geary felt ready to undertake and here Sothic Bioscience was born.

Speaking at the Business Plan final in Google, CEO Stephen Geary said, "Winning this year’s Ireland Funds’ Business Plan Competition will have a transformative effect on our business. The money will allow us to jumpstart our Intellectual Property strategy as well as our R&D internally."

Judges at the event included Founder & Managing Partner at Atlantic Bridge Ventures - Brian Long, Associate at Highland Capital Europe - Will McMahon, Director of Strategy Google - Neil O’Herlihy, 
Chairman of The Ireland Funds - Ronan Foley, CEO of Blueface - Alan Foy, Executive Director at Innovation Academy - Barbara Diehl and Chair of the Judging Panel and Managing Partner of Ravensdale Capital LLC, Angela Moore.

Source: www.businessworld.ie

More articles from Ireland

image Description

National Women’s Enterprise Day 2017

Read more
image Description

A third of Irish SME's suffered bad debt over the last 12 months

Read more
image Description

Ryanair pilots may be forced to change holiday plans

Read more
image Description

Irish SMEs Embrace Online Tools for Exporting

Read more
image Description

100 Construction jobs to be created in Charlemont Exchange redevelopment

Read more